Advancing Treatment for C3G; Targeting the Complement System for Personalized Kidney Care - Episode 2
Panelists discuss how C3 glomerulopathy (C3G) is triggered by factors like infections or pregnancy that activate the alternative pathway in genetically predisposed individuals, presenting with diverse clinical manifestations that often overlap with other glomerular diseases, making diagnosis challenging without kidney biopsy.
Video content above is prompted by the following:
C3G Clinical Insights Summary
This summary captures key points from a discussion between Jonathan Barratt, MBChB, PhD, FRCP,and other panelists regarding C3G.
Triggers and Pathogenesis
Diagnostic Challenges
C3G must be considered in the differential diagnosis for any glomerular disease presentation, regardless of complement levels, due to its highly variable presentation and overlap with other kidney disorders.